The production of basic pharmaceutical products and pharmaceutical preparations in South Korea has shown several notable trends. Between 2013 and 2019, there was a steady increase, peaking at 22.698 trillion South Korean Wons in 2019. However, 2020 saw a significant 14.19% decline, likely impacted by global economic disruptions. In 2021, production rebounded strongly with a 36.79% increase, reaching 26.642 trillion South Korean Wons. The subsequent years saw a minor decline and modest growth, standing at 25.683 trillion South Korean Wons in 2023. The compound annual growth rate (CAGR) over the last five years has been 2.73%.

Future trends to watch for include:

Steady growth with a forecasted 5-year CAGR of 2.13%, leading to a projected value of 29.607 trillion South Korean Wons by 2028.
Potential market disruptions or accelerations due to technological advancements, regulatory changes, and global health scenarios.
Increased investment in biotechnology and personalized medicine, which could significantly influence production volumes.